Questions That Matter to Your Development Decisions
Selecting the right chemistry partner involves more than capabilities. It requires clarity, trust, and technical confidence. Below are answers to common questions we receive from pharmaceutical, biotech, and research teams exploring collaboration with Elitekem Laboratories. If you need additional information, our team is always available to help.
Frequently Asked Question
1. How early in development can Elitekem support a project?
Elitekem supports projects from early discovery and pre-IND stages through advanced development. We frequently engage during route scouting, feasibility studies, and early analytical evaluation to help establish strong foundations for later stages..
2. How do you approach projects involving complex or novel chemistries?
Each project begins with a detailed scientific assessment. Our chemists evaluate molecular structure, reaction pathways, potential risks, and scalability before proposing an optimized synthesis or analytical strategy tailored to the molecule.
3. Can you support projects that require frequent changes or iterative development?
Yes. Our workflows are designed to be flexible. We routinely support iterative research programs where synthesis routes, specifications, or analytical needs evolve as development progresses.
4. How do you ensure data integrity and reproducibility across batches?
We follow structured documentation practices, validated analytical methods, and controlled workflows. Every batch is supported with clear analytical data to ensure consistency, traceability, and reproducibility.
5. What types of impurities can Elitekem identify and characterize?
We support detection and characterization of process-related impurities, degradation products, residual solvents, and genotoxic impurities using advanced chromatographic and spectroscopic techniques.
6. How do you handle projects without available reference standards?
When reference standards are unavailable, we develop analytical strategies to identify and characterize unknown materials. This includes impurity isolation, structural elucidation, and quantification based on validated methods.
7. What peptide lengths and complexities can you support?
We synthesize peptides ranging from short sequences to long and complex chains. Depending on sequence length and complexity, we apply solid-phase, solution-phase, or hybrid synthesis strategies.
8. Can you support modified and functionalized peptides?
Yes. Our expertise includes cyclic peptides, multiple disulfide bonds, PEGylation, azido-peptides for click chemistry, salt formation, and other advanced modifications.
9. How do you determine the most suitable synthesis route for an API or intermediate?
We conduct thorough route scouting that considers feasibility, safety, scalability, yield, and impurity risk. Alternative routes are evaluated before finalizing the most efficient and robust approach.
10. Do your analytical methods align with regulatory expectations?
Our analytical methods and documentation are developed with global regulatory pathways in mind and are suitable for supporting development programs and regulatory submissions.
11. How do you manage confidentiality and intellectual property protection?
All projects are handled under strict confidentiality agreements. Access to sensitive data is controlled, and intellectual property protection is treated as a core responsibility.
12. Can Elitekem support both research-scale and development-scale projects?
Yes. We work across milligram, gram, and development-scale quantities, adapting processes and analytical controls based on project stage and objectives.
13. How involved are clients during the project lifecycle?
We maintain transparent communication throughout the project. Clients receive structured updates, analytical results, and clear timelines to ensure alignment at every stage.
14. What information is required to initiate a project discussion?
Basic details such as molecular structure, target quantity, intended application, and timelines help us evaluate feasibility and propose an appropriate technical approach.
15. How does Elitekem differentiate itself from larger CDMOs?
Elitekem offers direct access to experienced scientists, flexible engagement models, and chemistry-first problem solving. This allows us to respond faster, adapt workflows, and maintain close technical collaboration.